Genetic Signatures is exhibiting at ASM Microbe 2025!
Genetic Signatures is a specialist molecular diagnostics (MDx) company focused on the development of multiplex PCR solutions for routine detection for infectious disease.
Our proprietary 3base® technology provides hospital and diagnostic laboratories with the ability to screen for a broad range of gastrointestinal parasites with a high degree of accuracy and reliability, in a rapid throughput (time to result) environment.
Visit our team to learn more about our unique diagnostic solutions for gastrointestinal parasites at
Booth #1130
Genetic Signatures' FDA 510(k) cleared solution
The EasyScreen™ Gastrointestinal Parasite Detection Kit & Automated Workflow can detect 8 of the most common GI parasites in a single test
Diagnose with Precision, Treat with Confidence
The EasyScreen™ Gastrointestinal Parasite Detection Kit and GS1 automated workflow offers a significant advancement in clinical diagnostics for expanded gastrointestinal (GI) parasite testing, providing healthcare professionals with a powerful, innovative tool for accurate and timely diagnosis.
Utilising patented 3base® technology, this highly sensitive gastrointestinal parasite panel can identify the eight most common and clinically relevant gastrointestinal parasites in a single test, from a single patient sample.
The automated workflow addresses the many challenges of highly manual and complex microscopic examinations. Our GS1 automated system performs sample extraction and PCR set-up, to provide a significant walkaway time and same-day reporting.
This rapid turnaround enables timely and appropriate patient management, significantly reducing healthcare costs.
Find out how EasyScreen™ and GS1 automation can transform your laboratory operations.
Don't risk a missed diagnosis
Traditional methods may only be 50% accurate
The life cycle of enteric parasites may be several days, or even up to 2 weeks in the case of Cyclospora spp. This causes sporadic shedding, creating a sensitivity challenge for diagnosis by traditional microscopy methods.
Ova & Parasite detection by microscopy requires several stool samples collected over several days to achieve a reasonable diagnostic sensitivity.
- 1 stool sample → ~50% accuracy
- 2 stool samples → ~75% accuracy
- 3 stool samples → ~90% accuracy
- Easyscreen™ Gastrointestinal Parasite Detection Kit → 98.8 - 99.6% accuracy
Based on FDA clinical trial results across 8 gastrointestinal parasites. Lowest accuracy of 98.8% for Giardia spp. Highest accuracy of 99.6% for Entamoeba histolytica.
Requiring only 1 patient sample, the Easyscreen™ Gastrointestinal Parasite Detection Kit provides reliable detection of the 8 most common enteric parasites for up to 60 patient samples simultaneously.
Hear from parasitology expert Lynne Garcia to learn more.
Free on-demand resources available on this topic
Webinar:
The burden of gastrointestinal parasites and advanced in ova and parasite diagnostic screening
Access free on-demand webinars
Webinar:
Molecular O&P - A streamlined workflow for ova and parasite testing and patient management
Access free on-demand webinars
Webinar:
Syndromic PCR testing for GI parasites including Dientamoeba fragilis and microsporidia, and their role in gastrointestinal disease
Access free on-demand webinars
White Paper:
Advances in Gastrointestinal Protozoa Testing: Molecular Ova and Parasite investigations
Download the white paper
Watch:
Molecular testing for Intestinal Protozoa: How a laboratory developed test compares to one that is FDA-cleared
Presented by Dr Susan Madison-Antenucci
Lab Chief of Bloodborne and Parasitic Diseases, New York State Department of Health, Wadsworth Center
Assistant Professor - Biomedical Sciences. Assistant Professor - Environmental Health Sciences, College of Integrated Health Sciences, University at Albany.
Section Editor for PLOS Neglected Tropical Diseases
Infections with intestinal parasitic protozoa are frequently underdiagnosed. Contributing factors include lack of knowledge regarding the prevalence in economically developed countries, poor sensitivity for traditional microscopy-based testing algorithms and lack of ability to test for some parasites. Sensitive, comprehensive and efficient testing methods are key for detection of intestinal parasites in clinical and reference laboratories.
Dr Madison-Antenucci discussed the comparison of laboratory-developed multiplex real-time PCR tests with the FDA-cleared Genetic Signatures Gastrointestinal Parasite Detection test. Specimens submitted to a reference laboratory for confirmation testing were retrospectively tested using the Genetic Signatures assay. Overall, 225 specimens were tested by both methods and showed good concordance for detection of Cryptosporidium sp., Cyclospora cayetanensis, Giardia duodenalis, Dientamoeba fragilis, Blastocystis sp. and Entamoeba histolytica, which are included in both assays.
Empower your laboratory
The GS1 automated platform provides medium and high throughput molecular solutions for EasyScreen™ diagnostic kits.
Benefits & features
- Performs sample extraction and PCR setup
- Fast sample processing of up to 60 samples for the EasyScreen™ Gastrointestinal Parasite Detection Kit
- 96-well PCR setup on one platform
- Significant walk-away-time and improved laboratory workflow
- Wizard-driven interface enables on-board sample and reagent traceability, and supports minimal wastage
- Small footprint allows improved use of space
Detect coinfections for earlier treatment
Gastrointestinal parasites often present as coinfections.
A large proportion of patient stool samples containing enteric parasites contain more than one species.
Due to the unique antibiotic treatment requirements of enteric parasite species, the simultaneous detection of all pathogens is essential to quickly deliver appropriate medical intervention, ensuring the best possible patient outcomes and antimicrobial stewardship.
"Cryptosporidium and Giardia are the two primary parasites that all of the
labs in the United States see, and we do a number of different types of
tests for them. They cause a significant burden on our population in terms
of work loss and economic productivity. The symptoms of Cryptosporidium
and Giardia infection can last for weeks."
Dr Lexi Bracken
Meet the ASM Microbe team
Allison Rossiter
Chief Executive Officer
Raymond Bouyea
Molecular Instrument Specialist
John Roberto
Molecular Instrument Specialist
Sarah Peaty
Head of Sales & Service
Angela Curtis
Head of Global Marketing & Product Strategy
Contact your local Genetic Signatures' representative
